Hctz and Eosinophil count increased - a phase IV clinical study of FDA data

Summary:

Eosinophil count increased is reported as a side effect among people who take Hctz (hydrochlorothiazide), especially for people who are female, 60+ old, also take Spiriva, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Eosinophil count increased when taking Hctz. It is created by eHealthMe based on reports of 23,493 people who have side effects when taking Hctz from the FDA, and is updated regularly.

What is Hctz?

Hctz has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 24,823 Hctz users. Check the latest studies of Hctz.

What is Eosinophil count increased?

Eosinophil count increased is found to be associated with 768 drugs and 1,129 conditions by eHealthMe. Check the latest studies of Eosinophil count increased.

On Jul, 08, 2026

23,493 people reported to have side effects when taking Hctz.
Among them, 11 people (0.05%) have Eosinophil count increased.

Could Hctz cause Eosinophil count increased?

Among these 11 people:

What is the gender of people who have Eosinophil count increased when taking Hctz? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Eosinophil count increased when taking Hctz? *

What are other drugs people take besides Hctz? *

What are other side effects people have besides Eosinophil count increased? *

Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 5 people, 45.45%
Asthma: 5 people, 45.45%
Pulmonary Function Test Decreased: 5 people, 45.45%
Inflammation: 2 people, 18.18%
Joint Pain: 2 people, 18.18%
Cough: 2 people, 18.18%
Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 2 people, 18.18%
Gastric Ulcer (stomach ulcer): 2 people, 18.18%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 18.18%
Gastrointestinal Mucosal Disorder (disorder of gastrointestinal lining mucous membranes): 2 people, 18.18%

What are the existing conditions these people have? *

Spinal Column Stenosis (narrowing of spinal column): 4 people, 36.36%
High Blood Cholesterol: 4 people, 36.36%
Asthma: 3 people, 27.27%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 18.18%
Cough: 2 people, 18.18%
Aneurysm (enlargement of an artery caused by a weakening of the artery wall): 2 people, 18.18%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 18.18%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 18.18%
Pain: 2 people, 18.18%
Nausea And Vomiting: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Hctz and have Eosinophil count increased?

- Check whether Eosinophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hctz:

Hctz (24,823 reports)

Browse all side effects of Hctz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eosinophil count increased:

Eosinophil count increased (768 drugs)

Browse all the conditions that are associated with Eosinophil count increased:

Eosinophil count increased (1,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide (the active ingredients of Hctz) and Hctz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.